Nurx Stock

nurx.comHealthcareFounded: 2015Funding to Date: $90.87MM

Nurx is a healthcare technology offering primary care solutions including birth control, HPV testing, PrEP for HIV prevention, and STI testing and treatment.

Register for Details

For more details on financing and valuation for Nurx, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Nurx.

Register Today

Team

Management Team

Edvard Engesaeth MD
Innovation Officer and Co-Founder
Sheena Deol
Executive Assistant
Ted Kraus
Advisor
Jonathan Czaja
Chief Operating Officer
Matthew Dzaman
Head, Engineering
Varsha Rao
Chief Executive Officer
Hans Gangeskar
Co-Founder & Board Member
Michael Hourie
Head of Finance

Board Members

Noah Knauf
Kleiner Perkins
Hans Gangeskar
Chelsea Clinton Ph.D
Clinton Foundation
Regina Benjamin MD

Other companies like Nurx in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Nurx expects to be profitable by early next year.
Efforts to get at-home test kits for the COVID-19 coronavirus are ramping up quickly, and two more health industry startups are bringing their own products to market, with both Carbon Health and Nurx starting to ship their own in-home sample collection kits. Both of these new offerings are the same…
Nurx, a health tech company that is providing convenient and affordable care for sensitive needs, announced it raised $52 million.